Reported Friday, Decoy Therapeutics Enters Up To $21M Private Placement With Healthcare Investor At $5.91 Per Share To Advance Lead Asset Into Clinical Trials

Benzinga Newsdesk www.benzinga.com Positive 66.8%

Neg 0% Neu 0% Pos 66.8%

Comments

No comments yet. Be the first!